600 patients66,869 observations120 daysLIVE

Patient P-01347

Synthetic patientNBL-101 · Day 120 · 65–74 · F · baseline S01Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
15%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S01
  2. Day 25 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 56 HY-01 recommendedHydration Protocol HY-01
  4. Day 57 Patient declinedNot now

What changed?

Trajectory began diverging from predicted response on Day 25.

Primary contributors, last 14 days
  • Nutritional resilience+9
  • GI instability-6
  • Treatment adherence-6
  • Toxicity+5
  • Inflammatory activity-4

What helped?

  • Hydration Protocol HY-01Day 56
    Declined by patient
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
11.5/100
worsening · +1.7 vs previous 14 d
Toxicity
Blood
24.4/100
worsening · +4.7 vs previous 14 d
Sleep quality
Wearable
54.1/100
worsening · -4.7 vs previous 14 d
Energy level
Daily log
6.1/10
worsening · -0.3 vs previous 14 d
Stress level
Daily log
4.8/10
worsening · +0.2 vs previous 14 d
Steps
Wearable
4,694
worsening · -221 vs previous 14 d
Adherence
Companion
81.6 %
stable · -1.9 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards restoration · 73 from the failing basin, 53 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
Would not help
  • Nothing clearly counter-productive in the record.
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Insoluble fibre
    +2no signal · 40%
  • Simple carbohydrates
    -1.2no signal · 19%
  • Spicy / capsaicin
    +1.2no signal · 20%
  • Alcohol
    -1no signal · 18%
  • Dietary fat load
    -0.6no signal · 15%
  • Histamine load
    -0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Intermediate metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 4.3 · butyrate capacity 78/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisNormal
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    46 ms
    Sleep
    7.1 h
    Steps
    3,713
    Resting HR
    62 bpm
    Daily log: GI score 12, nutritional resilience 71, adherence 82.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0138420%S0882
    P-0146020%S1282
    P-0147720%S1980
    P-0142220%S1680
    P-0147120%S1979
    P-0130620%S0279
    P-0143920%S18ME-01improved79
    P-0148920%S0278
    P-0149320%S1878
    P-0137820%S0877
    P-0130821%S0477
    P-0131620%S1077